147 related articles for article (PubMed ID: 15529439)
1. Ximelagatran, a new oral anticoagulant--how will it affect laboratory practice? A clinical perspective.
Machin SJ
Lab Hematol; 2004; 10(3):172-3. PubMed ID: 15529439
[No Abstract] [Full Text] [Related]
2. Ximelagatran, a new oral anticoagulant--how will it affect laboratory practice? A laboratory perspective.
Kottke-Marchant K
Lab Hematol; 2004; 10(3):173-5. PubMed ID: 15529440
[No Abstract] [Full Text] [Related]
3. Ximelagatran: a new type of oral anticoagulant.
Kwok L; Molckovsky D; Boucher M
Int J Technol Assess Health Care; 2005; 21(4):480-6. PubMed ID: 16262971
[TBL] [Abstract][Full Text] [Related]
4. Changing the guard in long-term anticoagulation: clinical and economic implications.
Lepor NE
Rev Cardiovasc Med; 2004; 5 Suppl 5():S22-9. PubMed ID: 15619612
[TBL] [Abstract][Full Text] [Related]
5. [Prescription and monitoring of anticoagulant therapies].
Laviolle B; Oger E
Rev Prat; 2008 Nov; 58(18):2063-70. PubMed ID: 19143281
[No Abstract] [Full Text] [Related]
6. A step change in oral anticoagulation: lack of coagulation monitoring with ximelagatran.
Carlsson SC; Schulman S
Semin Vasc Med; 2005 Aug; 5(3):259-65. PubMed ID: 16123913
[TBL] [Abstract][Full Text] [Related]
7. College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: laboratory monitoring of oral anticoagulant therapy.
Fairweather RB; Ansell J; van den Besselaar AM; Brandt JT; Bussey HI; Poller L; Triplett DA; White RH
Arch Pathol Lab Med; 1998 Sep; 122(9):768-81. PubMed ID: 9740135
[TBL] [Abstract][Full Text] [Related]
8. The potential for changing prescribing patterns from warfarin to oral direct thrombin inhibitors: clinical scenarios.
Reiffel JA
Rev Cardiovasc Med; 2004; 5 Suppl 5():S12-21. PubMed ID: 15619610
[TBL] [Abstract][Full Text] [Related]
9. A profit-thinner. Hospitals, docs await substitute for risky warfarin.
Becker C
Mod Healthc; 2005 Jul; 35(30):32-3. PubMed ID: 16101253
[No Abstract] [Full Text] [Related]
10. Ximelagatran: pharmacokinetics and pharmacodynamics of a new strategy for oral direct thrombin inhibition.
Kereiakes DJ
Rev Cardiovasc Med; 2004; 5 Suppl 5():S4-11. PubMed ID: 15619615
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and pharmacodynamics of ximelagatran.
Wolzt M; Sarich TS; Eriksson UG
Semin Vasc Med; 2005 Aug; 5(3):245-53. PubMed ID: 16123911
[TBL] [Abstract][Full Text] [Related]
12. Monitoring treatments with unfractionated heparin: CTAD must be used instead of citrate as the anticoagulant solution when using partial-draw collection tubes. Results of a multicenter evaluation.
Toulon P; Abecassis L; Smahi M; Ternisien C
Thromb Res; 2010 Dec; 126(6):536-42. PubMed ID: 20950840
[TBL] [Abstract][Full Text] [Related]
13. Discovery of ximelagatran in an historical perspective.
Gustafsson D
Semin Vasc Med; 2005 Aug; 5(3):227-34. PubMed ID: 16123909
[TBL] [Abstract][Full Text] [Related]
14. Effect of ximelagatran on ischemic events and death in patients with atrial fibrillation after acute myocardial infarction in the efficacy and safety of the oral direct thrombin inhibitor ximelagatran in patients with recent myocardial damage (ESTEEM) trial.
Tangelder MJ; Frison L; Weaver D; Wilcox RG; Bylock A; Emanuelsson H; Held P; Oldgren J
Am Heart J; 2008 Feb; 155(2):382-7. PubMed ID: 18215612
[TBL] [Abstract][Full Text] [Related]
15. The oral direct thrombin inhibitor, ximelagatran, an alternative for anticoagulant treatment during the puerperium and lactation.
Hellgren M; Johansson S; Eriksson UG; Wåhlander K
BJOG; 2005 May; 112(5):579-83. PubMed ID: 15842280
[TBL] [Abstract][Full Text] [Related]
16. College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: introduction.
Brandt JT
Arch Pathol Lab Med; 1998 Sep; 122(9):765-6. PubMed ID: 9740134
[No Abstract] [Full Text] [Related]
17. A review of the oral direct thrombin inhibitor ximelagatran: not yet the end of the warfarin era..
Mohapatra R; Tran M; Gore JM; Spencer FA
Am Heart J; 2005 Jul; 150(1):19-26. PubMed ID: 16084146
[TBL] [Abstract][Full Text] [Related]
18. [Update of guidelines for patient self-management of oral anticoagulation].
Braun S; Völler H; Soppa C; Taborski U;
Dtsch Med Wochenschr; 2009 Apr; 134(14):695-700. PubMed ID: 19288399
[No Abstract] [Full Text] [Related]
19. Preface. Ximelagatran and oral direct thrombin inhibition.
McCullough PA
Rev Cardiovasc Med; 2004; 5 Suppl 5():S1. PubMed ID: 15619609
[No Abstract] [Full Text] [Related]
20. Ximelagatran: oral direct thrombin inhibition as anticoagulant therapy in atrial fibrillation.
Halperin JL
J Am Coll Cardiol; 2005 Jan; 45(1):1-9. PubMed ID: 15629364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
